Hi Linda! Did you know the DiaPrevent diabetes research study is available in the US? The study is enrolling 10 to 20 year olds recently diagnosed with Type 1 Diabetes.
In this phase III study, two out of three participants receive active drug and one out of three participants receives placebo (shots that look the same but without the active drug). Diamyd's active substance is a protein called glutamic acid decarboxylase (GAD).
The study is open only to US residents. Participation is strictly voluntary. Find out more at http://www.diaprevent.com
Comment Reply
Hi Linda! Did you know the DiaPrevent diabetes research study is available in the US? The study is enrolling 10 to 20 year olds recently diagnosed with Type 1 Diabetes.
In this phase III study, two out of three participants receive active drug and one out of three participants receives placebo (shots that look the same but without the active drug). Diamyd's active substance is a protein called glutamic acid decarboxylase (GAD).
The study is open only to US residents. Participation is strictly voluntary. Find out more at http://www.diaprevent.com
July 13, 2010 - 5:19amThis Comment
Reply